EA199900600A1 - Производные пиразола - Google Patents
Производные пиразолаInfo
- Publication number
- EA199900600A1 EA199900600A1 EA199900600A EA199900600A EA199900600A1 EA 199900600 A1 EA199900600 A1 EA 199900600A1 EA 199900600 A EA199900600 A EA 199900600A EA 199900600 A EA199900600 A EA 199900600A EA 199900600 A1 EA199900600 A1 EA 199900600A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- group
- atom
- substituents
- phenyl
- hydrogen atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Соединение, представленное формулой (I), или его соль;где Rи R, которые могут быть одними и теми же или различаться, каждый представляет собой атом водорода, атом галогена, гидроксильную группу, алкоксильную группу, аминогруппу, алкиламиногруппу, арильную группу или алкильную группу; Rи R, которые могут быть одними и теми же или различаться, каждый представляет собой атом водорода, атом галогена, алкоксильную группу, аминогруппу, алкиламиногруппу, арильную группу или алкильную группу; Rпредставляет собой атом водорода, алкильную группу, алкенильную группу, алкинильную группу, арильную группу или арилалкильную группу; Q представляет собой амидиногруппу, циклоалкильную группу, фенильную группу или группу в виде моноциклического гетероцикла, за исключением пиримидинильной группы, связанной с атомом N во 2-ом положении; G представляет собой содержащую азот насыщенную гетероциклическую структуру, представленную формулойгде Xпредставляет собой атом азота или CH, в этой структуре кольцо может иметь кетогруппу, а также может иметь один или более заместителей; Z представляет собой фенильную или гетероциклическую группу, которая может иметь один или более заместителей, в которой два заместителя в фенильной или гетероциклической группе могут быть соединены друг с другом, образуя кольцо, что в целом дает конденсированную бициклическую структуру; заместитель в Z и заместитель в G могут быть соединены друг с другом, образуя в целом конденсированную трициклическую или тетрациклическую структуру, и противоопухолевый агент, содержащий в качестве активного ингредиента это соединение или его соль.Международная заявка была опубликована вместе с отчетом о
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1211697 | 1997-01-27 | ||
PCT/JP1998/000300 WO1998032739A1 (fr) | 1997-01-27 | 1998-01-26 | Derives de pirazole |
Publications (2)
Publication Number | Publication Date |
---|---|
EA199900600A1 true EA199900600A1 (ru) | 2000-04-24 |
EA002101B1 EA002101B1 (ru) | 2001-12-24 |
Family
ID=11796592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA199900600A EA002101B1 (ru) | 1997-01-27 | 1998-01-26 | Производные пиразола |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1022270A4 (ru) |
KR (1) | KR20000070523A (ru) |
CN (1) | CN1105707C (ru) |
AU (1) | AU724394B2 (ru) |
CA (1) | CA2278677A1 (ru) |
EA (1) | EA002101B1 (ru) |
ID (1) | ID22017A (ru) |
NO (1) | NO314260B1 (ru) |
TW (1) | TW486478B (ru) |
WO (1) | WO1998032739A1 (ru) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6169086B1 (en) | 1997-01-27 | 2001-01-02 | Daiichi Pharmaceutical Co., Ltd. | Pyrazole derivatives |
WO2000005230A1 (fr) * | 1998-07-24 | 2000-02-03 | Daiichi Pharmaceutical Co., Ltd. | Derives de pyrazole et sels correspondants |
EP2266973A1 (de) | 2009-05-29 | 2010-12-29 | Bayer CropScience AG | Pyrazinylpyrazole |
EP2499130A1 (de) | 2009-11-11 | 2012-09-19 | Bayer CropScience AG | Neue diazinyl-pyrazolylverbindungen |
KR101663637B1 (ko) * | 2009-11-13 | 2016-10-07 | 제노스코 | 키나아제 억제제 |
CN108430976B (zh) * | 2015-12-16 | 2022-07-05 | 日本曹达株式会社 | 芳基唑化合物和有害生物防除剂 |
TW202120478A (zh) * | 2019-11-22 | 2021-06-01 | 美商富曼西公司 | 用於合成(3-氯-2-吡啶基)肼的新穎製程 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3472857A (en) * | 1966-02-03 | 1969-10-14 | Ciba Ltd | N-(3-pyrazolyl-propyl)-n'-phenyl piperazines |
JPS61129129A (ja) * | 1984-11-28 | 1986-06-17 | Kureha Chem Ind Co Ltd | 抗腫瘍剤 |
CA1279645C (en) * | 1986-02-27 | 1991-01-29 | Ineke Van Wijngaarden | Aryl-substituted (n-piperidinyl)methyl- and (n-piperazinyl)methylazoles having antipsychotic properties |
US4808621A (en) * | 1986-07-07 | 1989-02-28 | Warner-Lambert Company | Trans-6-[2-(N-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl]- or ethenyl]tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis |
TW312694B (ru) * | 1994-09-26 | 1997-08-11 | Daiichi Seiyaku Co |
-
1998
- 1998-01-26 EA EA199900600A patent/EA002101B1/ru not_active IP Right Cessation
- 1998-01-26 WO PCT/JP1998/000300 patent/WO1998032739A1/ja not_active Application Discontinuation
- 1998-01-26 KR KR1019997006768A patent/KR20000070523A/ko not_active Application Discontinuation
- 1998-01-26 EP EP98900736A patent/EP1022270A4/en not_active Withdrawn
- 1998-01-26 AU AU55771/98A patent/AU724394B2/en not_active Ceased
- 1998-01-26 CA CA002278677A patent/CA2278677A1/en not_active Abandoned
- 1998-01-26 ID IDW990743A patent/ID22017A/id unknown
- 1998-01-26 TW TW087101177A patent/TW486478B/zh active
- 1998-01-26 CN CN98803733A patent/CN1105707C/zh not_active Expired - Fee Related
-
1999
- 1999-07-26 NO NO19993628A patent/NO314260B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ID22017A (id) | 1999-08-26 |
CN1251578A (zh) | 2000-04-26 |
CA2278677A1 (en) | 1998-07-30 |
TW486478B (en) | 2002-05-11 |
EA002101B1 (ru) | 2001-12-24 |
KR20000070523A (ko) | 2000-11-25 |
CN1105707C (zh) | 2003-04-16 |
NO314260B1 (no) | 2003-02-24 |
AU724394B2 (en) | 2000-09-21 |
NO993628D0 (no) | 1999-07-26 |
EP1022270A1 (en) | 2000-07-26 |
EP1022270A4 (en) | 2002-01-30 |
NO993628L (no) | 1999-09-22 |
WO1998032739A1 (fr) | 1998-07-30 |
AU5577198A (en) | 1998-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK250386D0 (da) | Fremgangsmaade til fremstilling af heterocycliske forbindelser | |
ES8600288A1 (es) | Un procedimiento para la preparacion de derivados de quinolina. | |
WO2002000650A3 (en) | Novel compounds possessing antibacterial, antifungal or antitumor activity | |
HUP9802822A2 (hu) | Halogén-benzimidazol-származékok, intermedierjeik, előállításuk és a vegyületeket hatóanyagként tartalmazó mikrobicid készítmények | |
BR0008173A (pt) | Composto de amida e seu uso como campo técnico de medicina da invenção | |
CY1106522T1 (el) | Ετepοκυκλικη ενωση και αντικαρκινικο μεσο που πepιεχει την ιδια ως δραστικο συστατικο | |
CA2383466A1 (en) | Aromatic nitrogen-containing 6-membered cyclic compounds | |
DE60140456D1 (de) | Aza heterocyclische derivate und ihre therapeutische verwendung | |
DK0591528T3 (da) | Pyrazolo[1,5-a]pyrimidinderivat og antiinflammatorisk middel, der indeholder dette | |
HUP0204474A2 (hu) | 1H-imidazopiridin-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
NZ506247A (en) | Fungicidal 7-(alkyl, alkenyl, alkadienyl, cycloalkyl, cycloalkenyl or aryl)-[1,2,4]triazolo[1,5-a]pyrimidines | |
ATE141260T1 (de) | Indole fungizide | |
ATE129714T1 (de) | Heterocyclische biphosphonsäurederivate. | |
TW340115B (en) | Triazine derivatives and pharmaceutical composition for hepatitis the invention relates to triazine derivatives and pharmaceutical composition for hepatitis | |
ES552702A1 (es) | Procedimiento para la preparacion de nuevas (hetero)-aril-propilaminas | |
EA199900600A1 (ru) | Производные пиразола | |
UA85502C2 (en) | Diazaindole-dicarbonyl-piperazinyl antiviral agents | |
AP9901578A0 (en) | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents. | |
YU215190A (sh) | Imidazolovi fungicidi | |
DK0420121T3 (da) | Antitumormiddel | |
RU2001114213A (ru) | Циклоалкилзамещенное производное аминометилпирролидина | |
WO2001044207A8 (fr) | Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2 4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant | |
DE60144246D1 (de) | Imidazolderivate, verfahren zu deren herstellung und deren verwendung | |
ES8404981A1 (es) | Un procedimiento para preparar guanidino-fenilamidinas heterociclicas sustituidas. | |
ES8500941A1 (es) | Procedimiento para preparar derivados de ciano-2-imidazopiridina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |